REBEL VIVIENNE I enters BIOAFFINITY TECHNOLOGIES, INC. with 7.14K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 11/22/2022ACC: 0001493152-22-033368
Officer· EVP, Chief Sci. & Med. Officer
Since Aug 2022
7.14K
Baseline shares
100% direct
7.14K
Direct ownership
1 position
14.28K
Derivative underlying
4 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock, par value $0.007
DirectShares owned7.14K
Total
7.14K direct7.14K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock, par value $0.007 | 7.14K | Direct |
| Total | 7.14K | 7.14K direct |
Derivative Holdings4
Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
4.29K
Shares owned
N/A
Exercise price
7.70
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
2.86K
Shares owned
N/A
Exercise price
7.70
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
4.29K
Shares owned
N/A
Exercise price
7.70
Expiration
—
Exercise window
—
Stock Option (right to buy)
DirectUnderlying security
Common Stock
Underlying shares
2.86K
Shares owned
N/A
Exercise price
7.00
Expiration
—
Exercise window
—
Total
Underlying
14.28K
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock | 7.70 | — | — | 4.29K | N/A |
| Stock Option (right to buy) Direct | Common Stock | 7.70 | — | — | 2.86K | N/A |
| Stock Option (right to buy) Direct | Common Stock | 7.70 | — | — | 4.29K | N/A |
| Stock Option (right to buy) Direct | Common Stock | 7.00 | — | — | 2.86K | N/A |
| Total | 14.28K | 0.00 | ||||